The development of immunosuppression: the rapamycin milestone.
Calne
R Y
RY
Department of Surgery, University of Cambridge, Addenbrook Hospital, Cambridge, UK.
D000818:Animals; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D023421:Models, Animal; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use; D014181:Transplantation Immunology
D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus